House’s prominent China critic Jim McGovern leads opposition to Biosecure Act: ‘I would prefer to go back to the drawing board’

Jared Whitlock

Features Editor

A Massachusetts lawmaker who frequently criticizes China has become the unlikely face of opposition to legislation that seeks to blacklist Chinese contractors like WuXi Biologics …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

House’s prominent China critic Jim McGovern leads opposition to Biosecure Act: ‘I would prefer to go back to the drawing board’

Jared Whitlock

Features Editor

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

FDA says Ozempic, Wegovy shortage is over

Kevin Tang's Concentra tries to disrupt proposed Acelyrin-Alumis merger

Pfizer ends rollout of Beqvez, putting another dent in hemophilia gene therapy field

Merck KGaA tees up changes to leadership team; Ex-CVS Health CEO joins Thermo Fisher’s board

Roche no longer wants to be where ‘DNA sequencing goes to die’

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

House’s promi­nent Chi­na crit­ic Jim Mc­Gov­ern leads op­po­si­tion to Biose­cure Act: ‘I would pre­fer to go back to the draw­ing board’

Features Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

House’s prominent China critic Jim McGovern leads opposition to Biosecure Act: ‘I would prefer to go back to the drawing board’